The FDA committed Friday to create a plan for how devices distributed throughout the Covid-19 emergency will transition to the market after the pandemic ends.
The promise of a transition is among the list of guidance documentsthe FDA said it intends to publish in the coming year.
Ventilators, face masks, and swabs would all theoretically fall under that category. Ushering them through a regular approval process will be relatively easy because the Food and Drug Administration uses a standard that compares new products to their older counterparts.
How Covid-19 tests will make the transition could be more complicated because ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.